BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 23758705)

  • 1. CDC20 overexpression predicts a poor prognosis for patients with colorectal cancer.
    Wu WJ; Hu KS; Wang DS; Zeng ZL; Zhang DS; Chen DL; Bai L; Xu RH
    J Transl Med; 2013 Jun; 11():142. PubMed ID: 23758705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comprehensive analysis of CDC20 overexpression in common malignant tumors from multiple organs: its correlation with tumor grade and stage.
    Gayyed MF; El-Maqsoud NM; Tawfiek ER; El Gelany SA; Rahman MF
    Tumour Biol; 2016 Jan; 37(1):749-62. PubMed ID: 26245990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased CDC20 expression is associated with development and progression of hepatocellular carcinoma.
    Li J; Gao JZ; Du JL; Huang ZX; Wei LX
    Int J Oncol; 2014 Oct; 45(4):1547-55. PubMed ID: 25069850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Connection Between CDC20 Expression and Hepatocellular Carcinoma Prognosis.
    Zhang X; Zhang X; Li X; Bao H; Li G; Li N; Li H; Dou J
    Med Sci Monit; 2021 Mar; 27():e926760. PubMed ID: 33788826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased CDC20 expression is associated with pancreatic ductal adenocarcinoma differentiation and progression.
    Chang DZ; Ma Y; Ji B; Liu Y; Hwu P; Abbruzzese JL; Logsdon C; Wang H
    J Hematol Oncol; 2012 Apr; 5():15. PubMed ID: 22475564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Cdc20 suppresses the metastasis in triple negative breast cancer (TNBC).
    Song C; Lowe VJ; Lee S
    Breast Cancer; 2021 Sep; 28(5):1073-1086. PubMed ID: 33813687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High CDC20 expression is associated with poor prognosis in oral squamous cell carcinoma.
    Moura IM; Delgado ML; Silva PM; Lopes CA; do Amaral JB; Monteiro LS; Bousbaa H
    J Oral Pathol Med; 2014 Mar; 43(3):225-31. PubMed ID: 24044615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell division cycle proteinising prognostic biomarker of breast cancer.
    Cheng L; Huang YZ; Chen WX; Shi L; Li Z; Zhang X; Dai XY; Wei JF; Ding Q
    Biosci Rep; 2020 May; 40(5):. PubMed ID: 32285914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High expression of spindle assembly checkpoint proteins CDC20 and MAD2 is associated with poor prognosis in urothelial bladder cancer.
    Choi JW; Kim Y; Lee JH; Kim YS
    Virchows Arch; 2013 Nov; 463(5):681-7. PubMed ID: 23995871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CDC20 expression in oestrogen receptor positive breast cancer predicts poor prognosis and lack of response to endocrine therapy.
    Alfarsi LH; Ansari RE; Craze ML; Toss MS; Masisi B; Ellis IO; Rakha EA; Green AR
    Breast Cancer Res Treat; 2019 Dec; 178(3):535-544. PubMed ID: 31471836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cdc20/p55 mediates the resistance to docetaxel in castration-resistant prostate cancer in a Bim-dependent manner.
    Wu F; Lin Y; Cui P; Li H; Zhang L; Sun Z; Huang S; Li S; Huang S; Zhao Q; Liu Q
    Cancer Chemother Pharmacol; 2018 Jun; 81(6):999-1006. PubMed ID: 29605876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic relevance of BRD7 expression in colorectal carcinoma.
    Wu WJ; Hu KS; Chen DL; Zeng ZL; Luo HY; Wang F; Wang DS; Wang ZQ; He F; Xu RH
    Eur J Clin Invest; 2013 Feb; 43(2):131-40. PubMed ID: 23215825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COLORECTAL Polymeric Immunoglobulin Receptor Expression is Correlated with Hepatic Metastasis and Poor Prognosis in Colon Carcinoma Patients with Hepatic Metastasis.
    Liu F; Ye P; Bi T; Teng L; Xiang C; Wang H; Li Y; Jin K; Mou X
    Hepatogastroenterology; 2014 May; 61(131):652-9. PubMed ID: 26176052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spindle assembly checkpoint MAD2 and CDC20 overexpressions and cell-in-cell formation in gastric cancer and its precursor lesions.
    Kim Y; Choi JW; Lee JH; Kim YS
    Hum Pathol; 2019 Mar; 85():174-183. PubMed ID: 30448220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GTSE1, CDC20, PCNA, and MCM6 Synergistically Affect Regulations in Cell Cycle and Indicate Poor Prognosis in Liver Cancer.
    Zheng Y; Shi Y; Yu S; Han Y; Kang K; Xu H; Gu H; Sang X; Chen Y; Wang J
    Anal Cell Pathol (Amst); 2019; 2019():1038069. PubMed ID: 32082966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-regulation of Tim-3 is associated with poor prognosis of patients with colon cancer.
    Zhou E; Huang Q; Wang J; Fang C; Yang L; Zhu M; Chen J; Chen L; Dong M
    Int J Clin Exp Pathol; 2015; 8(7):8018-27. PubMed ID: 26339368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The bioinformatics and experimental analysis of the novel roles of virus infection-associated gene CDC20 for prognosis and immune infiltration in hepatocellular carcinoma.
    Li J; Zhang X; Yao L; Hu K
    Aging (Albany NY); 2022 May; 14(10):4513-4529. PubMed ID: 35622386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Karyopherin alpha 2 is a novel prognostic marker and a potential therapeutic target for colon cancer.
    Zhang Y; Zhang M; Yu F; Lu S; Sun H; Tang H; Peng Z
    J Exp Clin Cancer Res; 2015 Dec; 34():145. PubMed ID: 26626145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell division cycle 20 (CDC20) drives prostate cancer progression via stabilization of β-catenin in cancer stem-like cells.
    Zhang Q; Huang H; Liu A; Li J; Liu C; Sun B; Chen L; Gao Y; Xu D; Su C
    EBioMedicine; 2019 Apr; 42():397-407. PubMed ID: 30904606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CDC20 with malignant progression and poor prognosis of astrocytoma revealed by analysis on gene expression.
    Ding Y; Yu S; Bao Z; Liu Y; Liang T
    J Neurooncol; 2017 May; 133(1):87-95. PubMed ID: 28432586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.